Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences T (JAGLX)

72.58 -0.50 (-0.68%)
At close: 8:06 AM EDT
Loading Chart for JAGLX
DELL
  • Previous Close 73.08
  • YTD Return 3.48%
  • Expense Ratio 0.80%
  • Category Health
  • Last Cap Gain 24.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 5.1B
  • Beta (5Y Monthly) 0.74
  • Yield 0.07%
  • 5y Average Return --
  • Holdings Turnover 34.00%
  • Last Dividend 0.05
  • Inception Date Dec 31, 1998

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

5.1B

Net Assets

1998-12-31

Inception Date

Performance Overview: JAGLX

Trailing returns as of 5/8/2024. Category is Health.

YTD Return

JAGLX
3.48%
Category
7.95%
 

1-Year Return

JAGLX
8.25%
Category
30.16%
 

3-Year Return

JAGLX
4.73%
Category
16.10%
 

5-Year Return

JAGLX
11.08%
Category
15.71%
 

People Also Watch

Holdings: JAGLX

Top 10 Holdings (37.34% of Total Assets)

SymbolCompany% Assets
LLY
LLY 6.63%
UNH
UNH 5.96%
NOVO-B.CO
NOVO-B.CO 4.81%
MRK
MRK 3.56%
AZN.L
AZN.L 3.56%
ABBV
ABBV 3.21%
ABT
ABT 2.49%
SAN.PA
SAN.PA 2.46%
VRTX
VRTX 2.37%
BSX
BSX 2.29%

Sector Weightings

SectorJAGLX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: JAGLX

Research Reports: JAGLX

Top Mutual Funds